Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds that inhibit complement and/or suppress immune activity

Compounds that inhibit complement and/or suppress immune activity

US Patent 5808109 · Granted Sep 15, 1998

Estimated economic value: $1,063,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptors targeting TIM-12023
Antibodies that bind human CD27 and uses thereof2021
Treatment of chronic nephropathies using soluble complement receptor type I (sCR2017
Treatment of chronic nephropathies using soluble complement receptor type I (sCR2016
Methods and devices for aligning and coupling a roofing profile to a roof2016
Antibodies that bind human CD27 and uses thereof2015
8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as ant2015
Treatment for age-related macular degeneration and other diseases of the eye2014
Hydroxylthienoquinolones and related compounds as anti-infective agents2012
Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones2012
Isothiazoloquinolones and related compounds as anti-infective agents2012
8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as ant2011